A comparison has been made of the effects of the 2-nitroimidazole Ro-07-0582 on tumour growth delay after irradiation and tumour cell survival in vitro after irradiation in vivo. This compound has previously been shown to be a specific sensitizer of hypoxic cells. A dose of 1 mg/g body weight gave an enhancement ratio of 2*2 for both growth delay and cell survival in a system where high pressure oxygen has been shown to have no effect. However, while the hypoxic fraction in the tumour was estimated to be less than 10% from the growth delay curves, the survival curves gave a value in excess of 50%. This discrepancy probably reflects differences in the response of cells left in situ or removed and assayed in vitro.
Summary.-A comparison has been made of the effects of the 2-nitroimidazole Ro-07-0582 on tumour growth delay after irradiation and tumour cell survival in vitro after irradiation in vivo. This compound has previously been shown to be a specific sensitizer of hypoxic cells. A dose of 1 mg/g body weight gave an enhancement ratio of 2*2 for both growth delay and cell survival in a system where high pressure oxygen has been shown to have no effect. However, while the hypoxic fraction in the tumour was estimated to be less than 10% from the growth delay curves, the survival curves gave a value in excess of 50%. This discrepancy probably reflects differences in the response of cells left in situ or removed and assayed in vitro. WHETHER or not a tumour will recur the effects of modifying agents such as after radiotherapy depends on the lethal oxygen and radiation quality. However, effect of the radiation on the individual the criticism has been made that tumour tumour cells. However, while it is a regrowth after irradiation reflects damage relatively straightforward procedure to to all the components of the tumour and, measure this lethal effect on cells directly in particular, vascular damage may conin the laboratory, the clinician can only tribute significantly to the observed measure survival of the patient after growth delay (Brown and Howes, 1974) . treatment and, in certain limited condi-An agent which preferentially sensitizes tions, tumour regression and regrowth hypoxic cells to radiation should provide (e.g. Breur, 1966) . For instance, in prean excellent opportunity to study the liminary trials of the effect of an hypoxic relationship between cell survival in situ cell sensitizer on secondary human tu-and in vitro after irradiation in vivo, mours, the endpoint being used is regrowth since its effect should only be to modify of subcutaneous and lung nodules after the survival of hypoxic cells and it irradiation in the presence or absence should have no effect on damage to of the sensitizer (Thomlinson, personal vascular endothelium, which is presumably communication). Thus, there are prac-well oxygenated. tical reasons for studying the relationship This paper is therefore concerned between tumour growth delay and cell with a comparison of the effects of the survival in the laboratory.
2-nitroimidazole drug Ro-07-0582 (Roche In previous studies on tumour growth Products Ltd, Welwyn Garden City, delay and tumour cell survival in vitro Herts.) on tumour growth delay after after irradiation in vivo (McNally, 1973, irradiation and tumour cell survival as-1975) it was shown, in at least one type sayed in vitro after irradiation in vivo. of tumour, that removal of tumour cells This compound has been shown to be a from their normal environment after specific sensitizer of hypoxic cells in irradiation may lead to incorrect estimates vitro (Asquith et al., 1974) , giving a of in situ cellular radiosensitivity and of sensitizing enhancement ratio (the ratio of the x-ray dose to produce a given for each individual tumour to grow from effect without the drug to that with the treatment size to 11 mm. Tumours were drug) of 2f5 at a concentration of 5 mmol. standardized to a diameter of 8-5 mm at It has also been shown to sensitize treatment by adding or subtracting a corcells in vivo, a dose of rection throughout for the small difference hypoxic tumour cells . vo min size of individual tumours at irradiation. 1 mg/g body weight giving enhancement For each radiation dose group a mean time ratios from 1P7 to 2-2 for various endpoints to grow from 8-5 to 11 mm and its 95% measured using a number of murine confidence limits could then be calculated tumours (Fowler and Adams, 1975) . and plotted as a function of this dose.
For cell survival studies tumours were MATERIALS AND METHODS excised, either immediately or at various times after irradiation, and single cell
The tumour used in this study was a suspensions prepared as previously described fast growing anaplastic round-celled sarcoma (McNally, 1972) . An aliquot of the unirra-(Sarcoma F), growing in CBA mice and diated cell suspension was then exposed previously described by Hewitt (1966) . to a dose of 8 krad of 60Co gamma rays Small pieces of the tumour were transplanted and 5 x 105 of these " feeder " cells were by trochar subcutaneously on the ventral mixed with the test cells in 20 ml of Eagle's wall of the thorax into 2-3 month old male Minimum Essential Medium plus 15% foetal mice. Tumours were irradiated when they calf serum and antibiotics plus 0 25% Difco had reached a mean diameter of 8-9 mm. " Noble " agar. 4 ml of this suspension At this size the volume doubling time was was pipetted into a 50 mm plastic Petri about 24 h. The source of radiation was a dish containing a 3 ml "base" of 0-9% Pantak x-ray set operated at 240 kV and agar in medium so that the appropriate 15 mA (h.v.1 1-3 mm Cu, dose rate 240 number of test cells were mixed with 105 rad/min). Mice were anaesthetized with " feeder " cells. Four replicate plates were pentobarbitone sodium before irradiation. used for each tumour cell suspension. The Mice which did not receive the sensitizing cells were then incubated for 15-20 days drug were given 60 mg/kg of the anaesthetic; at 370C in a humidified atmosphere of those receiving the sensitizer had approxi-5% 002 in air. Macroscopic colonies were mately three-quarters of this dose since the counted and survival curves constructed. sensitizer itself had a mild anaesthetic effect. In some experiments the tumours were irradiated with their blood supply RESULTS occluded by a semicircular aluminium clamp The times for tumours to grow from applied between the tumour and the chest treatment size (8.5 mm) to 11 mm wall 15 min before the start of irradiation, diameter after exposure to various doses to render all the tumour cells hypoxic of x-rays (Denekamp and Harris, 1975) . Mice treated are plotte. as a fun of ter with Ro-07-0582 were given either 1 mg/g x-ray dose in Fg. 1. The tumours were body weight or 0-2 mg/g of the drug (disunclamped and animals were breathing solved in saline) by intraperitoneal injection air. The animals treated with Ro-07-0582 30 min before the start of irradiation. had received 1 mg/g 30 min before
In order to measure the gross response starting the irradiation. Each point repof tumours to radiation, each tumour was resents data from 6-8 animals, except measured 3-5 times per week over 3 mutually for that for 2000 rad plus Ro-07-0582 for perpendicular diameters until it reached a which there were only 4 mice. The mean diameter of 13-5 mm, when the mouse error bars in Fig. 1 represent the 95 % was killed. The geometric mean diameter confidence limits.
was calculated for each individual tumour for each day. Growth curves were then her 2 largest doses of radiation deconstructed by plotting the mean diameter livered to tumours that had received for a group of animals receiving the same the sensitizer (2500 and 3000 rad) protreatment against time. Dose-effect curves duced some apparent local cures, in that were constructed by measuring the time 2 of the 7 animals whose tumours had received 2500 rad and 5 of the 7 that mum estimates of the delay induced by had received 3000 rad had to be killed these 2 doses of radiation. The curve due to lung metastases at times when for tumours irradiated in the absence of there was no evidence of regrowth of the the sensitizer had the biphasic shape primaries. The 2 points in Fig. 1 indicharacteristic of a mixed population of cated by arrows therefore represent mini-oxic and hypoxic cells (Thomlinson and Craddock, 1967) . The effect of the sena dose of 2000 rad, if the drug was present sitizer was to displace the dose at which before irradiation, the delay in regrowth this biphasic shape became apparent from was 3 times greater than if it was absent about 2000 rad to probably well over but that adding the drug after irradiation 2500 rad (Fig. 1) . only increased the delay by 10-20%. Even at low doses of radiation some
The enhancement ratio for growth sensitization was apparently produced by delay measured from Fig. 1 
ranges from
Ro-07-0582. However, this was because 1725 for a growth delay of 9 days to there was a slight effect of the drug if 2-0 for a delay of 15 days. This deadministered after irradiation. Figure 2 pendence on the level of damage is shows growth curves for tumours receiving because of the biphasic nature of the 1000 rad alone or given 1 mg/g of the dose-effect curve for irradiations in the drug immediately after irradiation. The absence of the sensitizer, reflecting the effect of the drug was to increase the response of a mixed population of oxic and time taken to grow to 11 mm from 5 hypoxic cells. to 7*3 days. It is not possible to allow Figure 3 shows survival values for for this post-irradiation effect in calculat-the cells of this tumour irradiated in ing the radiosensitizing effect of Ro-07-vivo in the absence of the sensitizer and 0582 since it has been measured only assayed in vitro. The animals were after one dose of radiation. However, breathing air and the tumours were it is not likely to contribute significantly either clamped or unclamped. The line to the measured enhancement ratio since was drawn by eye through the points. Denekamp and Harris (1975) , using a Clamping the tumour did not significantly different transplanted tumour in CBA increase the resistance of the cells to mice (carcinoma NT), showed that for radiation, implying a large hypoxic frac- tion. The survival curves for cells from The enhancement ratio for 1 mglg unclamped tumours irradiated in the Ro-07-0582 was 2-2 and for 0-2 mg/g it presence of either 1.0 mg/g or 0-2 mg/g was 1-3. This independence of the enof Ro-07-0582 are shown in Fig. 4 . The hancement ratio on the x-ray dose consurvival curve for cells from unclamped trasts with the lack of a significant tumours irradiated in the absence of effect of Ro-07-0582 on growth delay the sensitizer, redrawn from Fig. 3 , has for x-ray doses less than about 1500 rad been included for comparison. The effect (Fig. 1 ). of the sensitizer was essentially dose modifying because of the large hypoxic fraction. The Do for irradiations in the DISCUSSION absence of the drug was 350 rad, that Figures 1 and 4 clearly demonstrate for irradiations in the presence of 1 mg/g that Ro-07-0582 is an effective sensitizer was 160 rad and for 0-2 mg/g it was of naturally occurring hypoxic cells in 270 rad. The x-ray dose enhancement tumours. If it can be assumed that the ratio for each drug concentration can delay in regrowth for doses larger than be taken as the ratio of the Do in the about 2000 rad is a reflection of the absence of the drug to that in its presence response of hypoxic cells (Fig. 1) , then because the drug was dose modifying. it is possible to estimate an enhancement ratio for hypoxic cells left in situ. This a value of about 50% (Hewitt and was done by constructing hypothetical Wilson, 1961) , so that any sensitization growth curves assuming uniform sen-by HPO would have been easily detected. sitization of the hypoxic cells by x-ray Hewitt expressed his results as the ratio dose enhancement ratios of 1-4, 2-0 and of the surviving fraction of cells after 2-2. These hypothetical curves are repre-irradiation of the tumour in mice breathing sented by the dashed lines in Fig. 1 . The air to that after irradiation breathing enhancement ratio of 1-4 does not fit oxygen, at a given dose of x-rays. Signithe data. The value of 2-0 probably ficant sensitization should give a ratio represents a minimum estimate of the of cell survival greater than 1 by one or enhancement ratio, while the value of more orders of magnitude, particularly 2-2 is in good agreement with the data at doses greater than 1000 rad. In the and also agrees with that deduced from Table Hewitt's results are compared with the survival curves (Fig. 4) .
the present ones using Ro-07-0582. The Hewitt (1966) studied the sensitizing smallest dose he used was 2040 rad but effect of high pressure oxygen (HPO) for all the x-ray doses used he found no on cell survival in the present tumour real effect of breathing oxygen. In the system and found no significant sensitizapresent experiments, however, a dose of tion using his dilution assay. He used 1000 rad killed 25 times more cells in this tumour because his previous estimate the presence of 1 mg/g Ro-07-0582 than of the hypoxic fraction had indicated in its absence and a dose of 2040 rad the doses of x-rays needed to produce the same loss of radioactivity when tumours were irradiated either clamped or would, by extrapolation of the curves unclamped, indicating that in the of Fig. 4 , increase this ratio to over 100. unclamped situation the proportion of The absence of an effect of oxygen in hypoxic cells was small. Hewitt's experiment may have been Thus, the 2 techniques in which cells because of its rapid metabolism, or beare left in situ (growth delay and loss cause of a vasoconstrictive effect of the of 1251 activity) gave lower estimates of high pressure (e.g. Lambertsen, 1966) .
the hypoxic fraction than those in which The 2 methods of assay used in the the cells are removed from the mice present study gave quite different esti-after irradiation (cell survival in Petri mates of the hypoxic fraction of cells in dishes and in recipient mice). A possible the tumour even though they gave the explanation for this discrepancy is that same estimate of the enhancement ratio " doomed " hypoxic cells which would for Ro-07-0582. As in Hewitt's results, die if left in situ, even though they have the hypoxic fraction was apparently well survived the radiation, are " rescued " over 50 % when it was determined by from death due to hypoxia when the the assay of cells in vitro since (a) there tumour is excised and a single cell suspenwas little effect of clamping the tumour tion obtained (McNally, 1973) . on cell survival ( Fig. 3) 
and (b) Ro-07-0582
In order to test this possibility, unwas essentially dose modifying ( Fig. 4) . clamped tumours were exposed to single In contrast, the growth delay curves doses of 2000 rad (animals breathing (Fig. 1 ) suggest that the " effective " in air), excised at various times after irradiasitu hypoxic fraction was probably well tion and the cells assayed for their colony below 10% because (a) the resistant forming ability. If hypoxic cells that portion did not affect the growth delay had survived the irradiation died due to curves at doses less than about 2000 rad hypoxia or other nutrient deficiency, and (b) there was little effect of Ro-07-0582 there should be a fall in survival as the below this dose.
interval between irradiation and excision Two other estimates of the hypoxic increased. Figure 5 shows that this was fraction in sarcoma F have been made. not the case; the surviving fraction of Hewitt and Wilson (1961) , as mentioned cells increased with time up to 8 h by above, deduced that the hypoxic fraction a factor of 5-10 and showed no consistent was about 50% when they assayed the change thereafter. The scatter in the cells by their dilution method in which data does not exclude a small fall in 10-1 -posed another explanation for the dis- . 3) , this would Time af ter irradiation (h) mean that even at the lowest dose of hypoxic cells plus this vascular damage. One would not then expect to see a survival, within the first hour or two, but biphasic response such as in Fig. 1 unless this is certainly not sufficient to account a portion of the vascular endothelium for the difference in the estimates of the were hypoxic. This seems unlikely. Furhypoxic fraction. The observed increase ther, there should be an effect of Ro-07in surviving fraction with time ( Fig. 5 ) 0582 at doses less than 2000 rad unless is probably due to recovery from poten-the effect of the vascular damage far tially lethal damage (Hahn and Little, outweighed that of cell killing in causing 1972), although if cells which had been growth delay. This, too, seems unlikely. killed by the radiation become pycnotic A more likely explanation for the and lysed soon after irradiation so that discrepancy in the estimates of the they were not counted in the haemacytohypoxic fraction is that assays which meter, this could lead to an apparent involve removal of cells from their normal increase in survival. This possibility can-environment after irradiation do not not be excluded although the yield of accurately reflect the course of events cells by the trypsinization procedure and in the undisturbed tumour (McNally, the proportion of intact cells in the 1973). It is known that the degree of haemacytometer did not noticeably change intercellular contact can affect a cell's with time between irradiation and ex-ability to absorb radiation damage as cision of the tumour. It can be concluded sub-lethal (Durand and Sutherland, 1972) . that either there was no progressive In tumours, it may differentially affect decrease in cell survival due to hypoxia, the radioresistance of hypoxic and aerobic or the recovery from potentially lethal cells. In particular, hypoxic cells may damage more than compensated for such be more radiosensitive when left in situ hypoxic death. than when plated in vitro. Alternatively, Brown and Howes (1974) have pro-the present results are consistent with more radioresistance of cells in contact (i.e. in situ) than when separated, if the cells are aerobic but not if they are hypoxic.
In summary, the results presented in this paper demonstrate that the 2-nitroimidazole Ro-07-0582 is an effective sensitizer of naturally occurring hypoxic tumour cells in a system where high pressure oxygen has been shown to have no effect. The sensitizing enhancement ratio deduced from the growth curves in which cells are left in situ (Fig. 1) is in agreement with that measured by the in vitro assay of cell survival (Fig. 4) . However, the 2 methods of assay give quite different estimates of the hypoxic fraction. This discrepancy is probably a reflection of differences in the expression of radiation damage by cells left in situ and those assayed in vitro.
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